Premium
Thrombosis of a patent foramen ovale closure device: Thrombolytic management
Author(s) -
Vanderheyden Marc,
Willaert Willem,
Claessens Philip,
Branders Inge,
Ex Paul,
Vermeersch Paul
Publication year - 2002
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.10253
Subject(s) - medicine , patent foramen ovale , paradoxical embolism , thrombosis , surgery , embolism , closure (psychology) , percutaneous , economics , market economy
Transcatheter closure of a patent foramen ovale (PFO) offers a valuable alternative to surgery in selected patients with presumed paradoxical embolism. Like for all other devices, several complications have been described. Although the majority of these complications are caused by technical problems of the device itself, thrombosis is a relatively infrequent but feared finding, as it may result in recurrent embolic events and persistent neurological deficits. The majority of the complications after implantation are dealt with by surgical removal of the device and subsequent surgical closure of the PFO. The present case report describes biatrial thrombosis of a PFO device that was successfully treated with thrombolytics and GP IIb/IIIa receptor blockers. In stable patients, this pharmaco‐therapeutic approach should be attempted to save the thrombosed PFO device and could therefore offer a valuable alternative to surgical removal of the device. Cathet Cardiovasc Intervent 2002;56:522–526. © 2002 Wiley‐Liss, Inc.